YIDU TECH INC. DL -00002 risk profile
58 Elevated one input has moved against it
Measured 1 September 2026 from 0EL's filed statements. Recomputed nightly.
58 (Elevated), driven by Cash conversion at 96, over 5 weighted categories on the SOFTWARE profile.
What is measured
| Mechanism | Reading | Band | Direction | Driver |
|---|---|---|---|---|
| Market expectation | 82 | Acute | Stable | Drawdown from the 52-week high — 44.9% |
| Operating pressure | 1 | Contained | Easing | Input-cost exposure — 0.01 |
| Cash conversion | 96 | Acute | Easing | Capital spending against operating cash — -1.35x |
| Leverage and coverage | 0 | Contained | Easing | Current ratio — 4.81x |
| Competitive position | 65 | Stretched | Stable | Revenue-growth gap against peers — -27.8 percentage points |
| Concentration | Reads identified supplier spend, customers above the 10% disclosure threshold and revenue by region. No reading is stored for this company. | |||
These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.
Healthcare companies with a risk reading
Lilly(Eli) & Company 17Johnson & Johnson 37Abbvie Inc 46Roche Holding AG 32Merck & Co Inc 26Novartis AG 25Astrazeneca plc 30AMGEN Inc 33Thermo Fisher Scientific Inc 45Novo Nordisk A/S 23Abbott Laboratories 43Gilead Sciences Inc 31
Financials, valuation and price history for YIDU TECH INC. DL -00002